UC San Francisco researchers have for the first time developed a strategy for targeting a key molecule implicated in Parkinson’s
Category: Parkinson’s disease
Using sleep disorder to predict Parkinson’s disease
A large multi-centre study of more than 1,200 patients provides important predictors of Parkinson’s disease progression, which will allow better
Depression linked to brain inflammation
Years of depression can cause brain inflammation that has been linked to degenerative diseases like Alzheimer’s and Parkinson’s, an analysis
Amantadine for treating Parkinson’s disease
FDA Approves Osmolex ER (amantadine) for the treatment of Parkinson’s disease and drug-Induced extrapyramidal reactions. Amantadine is an antiviral medicine
Calcium may cause Parkinson’s disease
The international team, led by the University of Cambridge, found that calcium can mediate the interaction between small membranous structures
Brain zaps for Tourette syndrome
Electric zaps can rewire the brains of Tourette syndrome patients, effectively reducing their uncontrollable vocal and motor tics. The procedure,
Brain cells may prevent Parkinson’s disease
A Norwegian study shows that impairment in mitochondria may actually protect the brain in Parkinson’s disease. Mitochondria are microscopic power
Links between Crohn’s and Parkinson’s disease
Mount Sinai Researchers have just discovered that patients in the Ashkenazi Jewish population with Crohn’s disease (a chronic inflammatory of
Dangers of using anaesthetics
A new understanding of the complex ways in which general anaesthetics act on the brain could eventually lead to improved
Gocovri drug for treatment of dyskinesia
Gocovri (amantadine) drug has been approved for treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy, with or
